Association of Interleukin 7 Immunotherapy With Lymphocyte Counts Among Patients With Severe Coronavirus Disease 2019 (COVID-19)

This case series examines whether interleukin 7 (IL-7) is associated with restored host protective immunity in patients with severe coronavirus disease 2019 (COVID-19) and immunosuppression.

Detalles Bibliográficos
Autores principales: Laterre, Pierre Francois, François, Bruno, Collienne, Christine, Hantson, Philippe, Jeannet, Robin, Remy, Kenneth E., Hotchkiss, Richard S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376391/
https://www.ncbi.nlm.nih.gov/pubmed/32697322
http://dx.doi.org/10.1001/jamanetworkopen.2020.16485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376391/
https://www.ncbi.nlm.nih.gov/pubmed/32697322
http://dx.doi.org/10.1001/jamanetworkopen.2020.16485

Ejemplares similares